Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
26,189
-
Shares change
-
-64,197
-
Total reported value, excl. options
-
$2,785,000
-
Value change
-
-$5,481,399
-
Put/Call ratio
-
50.33%
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$104.58
Significant Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q2 2021
28 filings reported holding CURE - DIREXION SHS ETF TR - HEALTHCARE BUL as of Q2 2021.
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,189 shares
.
Largest 10 shareholders include Traynor Capital Management, Inc. (8,484 shares), FLOW TRADERS U.S. LLC (6,627 shares), Capital Investment Advisors, LLC (3,005 shares), SIMPLEX TRADING, LLC (2,296 shares), Qube Research & Technologies Ltd (1,929 shares), Tower Research Capital LLC (TRC) (775 shares), Cutler Group LP (600 shares), MORGAN STANLEY (573 shares), BARCLAYS PLC (505 shares), and Ellis Investment Partners, LLC (401 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.